Promega Corporation

ViviRen™ In Vivo Renilla Luciferase Substrate

  • Xenogen Logo
  • Caliper Logo

ViviRen™ in vivo Renilla Luciferase Substrate is a uniquely engineered coelenterazine-based compound with protected oxidation sites. These modifications are designed to minimize substrate degradation and autoluminescence. It is reported that the ViviRen™ Substrate demonstrates brighter output when compared to the native coelenterazine substrate when used in an in vivo imaging application in a mouse model.

Cat.# P1231 is supplied as a liquid, 60mM in DMSO. Cat.# P1232 is supplied as a lyophilized solid.

VivoGlo™ In Vivo Imaging Substrates are provided in cooperation with Xenogen Corporation and Caliper Life S...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for China customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

ViviRen™ In Vivo Renilla Luciferase Substrate

Close Window

ViviRen™ In Vivo Renilla Luciferase Substrate

 Components

0.37mg
- P1231 ¥ 1,599.00 Add to cart

ViviRen™ In Vivo Renilla Luciferase Substrate

Close Window

ViviRen™ In Vivo Renilla Luciferase Substrate

 Components

Close Window
  • This product can be added to a

  • Helix Freezer

This product is available through the Promega Helix onsite stocking program in a –20°C Helix Freezer. The program offers numerous convenient solutions to meet your lab's needs. Helix Freezers are available in two sizes: 5.7 cubic ft. or 9.7 cubic ft.


Click here to learn more about the Helix Collection »


Already a Helix Customer?

Request to add this product to your Helix »


3.7mg
- P1232 ¥ 9,558.00 Add to cart


You Also May Be Interested In

Storage Conditions

Store at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

P1231, P1232 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

P1231, P1232 The use of this product and derivatives thereof is strictly limited to that of a life sciences research reagent. All other use is strictly prohibited, including but not limited to any diagnostic, therapeutic, or commercial use. The use of this product for in vivo bioluminescent imaging may be covered by one or more patents controlled by Caliper Life Sciences, Inc. Those patents include U.S. Pat. Nos. 5,650,135, 6,217,847, 6,923,951, 6,908,605, 6,890,515, and corresponding foreign patents and pending applications. The purchase or transfer of this product is not intended, either expressly or by implication, to grant any right or license to practice under the foregoing patents. Purchasers are advised to contact Caliper Life Sciences, Inc., 68 Elm St., Hopkinton, MA 01748 for information regarding a license to practice under such patents.

P1231, P1232 U.S. Pat. Nos. 7,268,229 and 7,537,912 and other patents and patents pending.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.